{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:12:15Z","timestamp":1785521535501,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12010-026-05725-7","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:14:12Z","timestamp":1779336852000},"page":"6259-6277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ungeremine suppresses colon cancer cell proliferation through inhibition of the PI3K\/AKT\/mTOR signaling pathway"],"prefix":"10.1007","volume":"198","author":[{"given":"Lijun","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9928-7315","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"3","key":"5725_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A., & Jemal, A. (2023). Colorectal cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(3), 233\u2013254. https:\/\/doi.org\/10.3322\/caac.21772","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"5725_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/nano12010169","volume":"12","author":"FA Al-Joufi","year":"2022","unstructured":"Al-Joufi, F. A., Setia, A., Salem-Bekhit, M. M., et al. (2022). Molecular pathogenesis of colorectal cancer with an emphasis on recent advances in biomarkers, as well as nanotechnology-based diagnostic and therapeutic approaches. Nanomaterials, 12(1), 169. https:\/\/doi.org\/10.3390\/nano12010169","journal-title":"Nanomaterials"},{"issue":"1","key":"5725_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q Li","year":"2024","unstructured":"Li, Q., Geng, S., Luo, H., et al. (2024). Signaling pathways involved in colorectal cancer: Pathogenesis and targeted therapy. Signal Transduction and Targeted Therapy, 9(1), 266. https:\/\/doi.org\/10.1038\/s41392-024-01953-7","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"5725_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He, Y., Sun, M. M., Zhang, G. G., et al. (2021). Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduction and Targeted Therapy, 6(1), 425. https:\/\/doi.org\/10.1038\/s41392-021-00828-5","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"5725_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano, A., Foo, A. S. C., Lam, H. Y., et al. (2023). PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Molecular Cancer, 22(1), 138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6","journal-title":"Molecular Cancer"},{"issue":"11","key":"5725_CR6","doi-asserted-by":"publisher","first-page":"5806","DOI":"10.3390\/ijms25115806","volume":"25","author":"R \u015awiechowski","year":"2024","unstructured":"\u015awiechowski, R., Pietrzak, J., Wosiak, A., Mik, M., & Balcerczak, E. (2024). Genetic insights into colorectal cancer: Evaluating PI3K\/AKT signaling pathway genes expression. International Journal of Molecular Sciences, 25(11), 5806. https:\/\/doi.org\/10.3390\/ijms25115806","journal-title":"International Journal of Molecular Sciences"},{"key":"5725_CR7","doi-asserted-by":"publisher","first-page":"101987","DOI":"10.1016\/j.toxrep.2025.101987","volume":"14","author":"M Tufail","year":"2025","unstructured":"Tufail, M. (2025). PTEN-mediated resistance in cancer: From foundation to future therapies. Toxicology Reports, 14, 101987. https:\/\/doi.org\/10.1016\/j.toxrep.2025.101987","journal-title":"Toxicology Reports"},{"key":"5725_CR8","doi-asserted-by":"publisher","first-page":"1516583","DOI":"10.3389\/fphar.2025.1516583","volume":"16","author":"M Qiang","year":"2025","unstructured":"Qiang, M., Chen, Z., Liu, H., et al. (2025). Targeting the PI3K\/AKT\/mTOR pathway in lung cancer: Mechanisms and therapeutic targeting. Frontiers in Pharmacology, 16, 1516583. https:\/\/doi.org\/10.3389\/fphar.2025.1516583","journal-title":"Frontiers in Pharmacology"},{"key":"5725_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117714","volume":"181","author":"J Yuan","year":"2024","unstructured":"Yuan, J., Yang, L., Zhang, H., et al. (2024). Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers. Biomedicine & Pharmacotherapy, 181, Article 117714. https:\/\/doi.org\/10.1016\/j.biopha.2024.117714","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"23","key":"5725_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25235621","volume":"25","author":"M Masi","year":"2020","unstructured":"Masi, M., Evidente, A., Meyer, C., & Cimmino, A. (2020). Advances in the chemical and biological characterization of Amaryllidaceae alkaloids. Molecules, 25(23), Article 5621. https:\/\/doi.org\/10.3390\/molecules25235621","journal-title":"Molecules"},{"issue":"4","key":"5725_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11418-016-0989-7","volume":"70","author":"K Habartov\u00e1","year":"2016","unstructured":"Habartov\u00e1, K., Cahl\u00edkov\u00e1, L., Havelek, R., & Opletal, L. (2016). The biological activity of alkaloids from the Amaryllidaceae. Journal of Natural Medicines, 70(4), 531\u2013544. https:\/\/doi.org\/10.1007\/s11418-016-0989-7","journal-title":"Journal of Natural Medicines"},{"issue":"23","key":"5725_CR12","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.1016\/j.bmcl.2011.09.097","volume":"21","author":"L Casu","year":"2011","unstructured":"Casu, L., Cottiglia, F., Leonti, M., et al. (2011). Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases. Bioorganic & Medicinal Chemistry Letters, 21(23), 7041\u20137044. https:\/\/doi.org\/10.1016\/j.bmcl.2011.09.097","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"6","key":"5725_CR13","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jobcr.2023.09.002","volume":"13","author":"S Jayaraman","year":"2023","unstructured":"Jayaraman, S., Natarajan, S. R., Veeraraghavan, V. P., & Jasmine, S. (2023). Unveiling the anti-cancer mechanisms of calotropin: Insights into cell growth inhibition, cell cycle arrest, and metabolic regulation in human oral squamous carcinoma cells (HSC-3). Journal of Oral Biology and Craniofacial Research, 13(6), 704\u2013713. https:\/\/doi.org\/10.1016\/j.jobcr.2023.09.002","journal-title":"Journal of Oral Biology and Craniofacial Research"},{"issue":"8","key":"5725_CR14","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.sdentj.2023.08.003","volume":"35","author":"S Jayaraman","year":"2023","unstructured":"Jayaraman, S., Natarajan, R., Ponnusamy, S., Veeraraghavan, B., V. P., & Jasmine, S. (2023). Unlocking the potential of beta sitosterol: Augmenting the suppression of oral cancer cells through extrinsic and intrinsic signalling mechanisms. The Saudi Dental Journal, 35(8), 1007\u20131013. https:\/\/doi.org\/10.1016\/j.sdentj.2023.08.003","journal-title":"The Saudi Dental Journal"},{"issue":"4","key":"5725_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12668-025-02244-3","volume":"15","author":"M Aruchamy","year":"2025","unstructured":"Aruchamy, M., Snega, R., Surya, M., & Muthupandian, S. (2025). Exploring the anticancer effect of reduced graphene oxide\u2013titanium dioxide (rGO-TiO\u2082) nanocomposite against oral cancer. BioNanoScience, 15(4), 1\u20137. https:\/\/doi.org\/10.1007\/s12668-025-02244-3","journal-title":"BioNanoScience"},{"issue":"4","key":"5725_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s12253-016-0066-5","volume":"22","author":"I Riquelme","year":"2016","unstructured":"Riquelme, I., Tapia, O., Espinoza, J. A., et al. (2016). The gene expression status of the PI3K\/AKT\/mTOR pathway in gastric cancer tissues and cell lines. Pathology & Oncology Research, 22(4), 797\u2013805. https:\/\/doi.org\/10.1007\/s12253-016-0066-5","journal-title":"Pathology & Oncology Research"},{"issue":"Pt 5","key":"5725_CR17","doi-asserted-by":"publisher","first-page":"127242","DOI":"10.1016\/j.ijbiomac.2023.127242","volume":"253","author":"M Prasad","year":"2023","unstructured":"Prasad, M., Jayaraman, S., Natarajan, S. R., et al. (2023). Piperine modulates IR\/Akt\/GLUT4 pathways to mitigate insulin resistance: Evidence from animal and computational studies. International Journal of Biological Macromolecules, 253(Pt 5), 127242. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.127242","journal-title":"International Journal of Biological Macromolecules"},{"issue":"6","key":"5725_CR18","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2021.2433","volume":"15","author":"SM Alzahrani","year":"2021","unstructured":"Alzahrani, S. M., Al Doghaither, H. A., & Al-Ghafari, A. B. (2021). General insight into cancer: An overview of colorectal cancer (Review). Molecular and Clinical Oncology, 15(6), Article 271. https:\/\/doi.org\/10.3892\/mco.2021.2433","journal-title":"Molecular and Clinical Oncology"},{"issue":"9","key":"5725_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28093823","volume":"28","author":"N Tarawneh","year":"2023","unstructured":"Tarawneh, N., Hamadneh, L., Abu-Irmaileh, B., Shraideh, Z., Bustanji, Y., & Abdalla, S. (2023). Berberine inhibited growth and migration of human colon cancer cell lines by increasing phosphatase and tensin and inhibiting aquaporins 1, 3 and 5 expressions. Molecules, 28(9), Article 3823. https:\/\/doi.org\/10.3390\/molecules28093823","journal-title":"Molecules"},{"issue":"8","key":"5725_CR20","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.7150\/jca.92087","volume":"15","author":"Q Zheng","year":"2024","unstructured":"Zheng, Q., Jing, S., Hu, L., & Meng, X. (2024). Evodiamine inhibits colorectal cancer growth via RTKs mediated PI3K\/AKT\/p53 signaling pathway. Journal of Cancer, 15(8), 2361\u20132372. https:\/\/doi.org\/10.7150\/jca.92087","journal-title":"Journal of Cancer"},{"key":"5725_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152832","volume":"60","author":"AT Mbaveng","year":"2019","unstructured":"Mbaveng, A. T., Bitchagno, G. T. M., Kuete, V., Tane, P., & Efferth, T. (2019). Cytotoxicity of ungeremine towards multi-factorial drug resistant cancer cells and induction of apoptosis, ferroptosis, necroptosis and autophagy. Phytomedicine, 60, Article 152832. https:\/\/doi.org\/10.1016\/j.phymed.2019.152832","journal-title":"Phytomedicine"},{"issue":"1","key":"5725_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/13880209.2023.2200787","volume":"61","author":"X Qi","year":"2023","unstructured":"Qi, X., Chen, Y., Liu, S., et al. (2023). Sanguinarine inhibits melanoma invasion and migration by targeting the FAK\/PI3K\/AKT\/mTOR signalling pathway. Pharmaceutical Biology, 61(1), 696\u2013709. https:\/\/doi.org\/10.1080\/13880209.2023.2200787","journal-title":"Pharmaceutical Biology"},{"key":"5725_CR23","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.2147\/OTT.S232137","volume":"13","author":"X Tian","year":"2020","unstructured":"Tian, X., Liu, M., Huang, X., et al. (2020). Noscapine induces apoptosis in human colon cancer cells by regulating mitochondrial damage and Warburg effect via PTEN\/PI3K\/mTOR signaling pathway. OncoTargets and Therapy, 13, 5419\u20135428. https:\/\/doi.org\/10.2147\/OTT.S232137","journal-title":"OncoTargets and Therapy"},{"issue":"53","key":"5725_CR24","doi-asserted-by":"publisher","first-page":"33572","DOI":"10.1039\/C7RA02994B","volume":"7","author":"L Xiao-ai","year":"2017","unstructured":"Xiao-ai, L., Bei, W., Xiao-hong, X., et al. (2017). Curcumin re-sensitizes multidrug resistant (MDR) breast cancer to cisplatin through inducing autophagy by decreasing CCAT1 expression. RSC Advances, 7(53), 33572\u201333579.","journal-title":"RSC Advances"},{"issue":"11","key":"5725_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biom11111605","volume":"11","author":"C Fernandes","year":"2021","unstructured":"Fernandes, C., Videira, A. J. C., Veloso, C. D., et al. (2021). Cytotoxicity and mitochondrial effects of phenolic and quinone-based mitochondria-targeted and untargeted antioxidants on human neuronal and hepatic cell lines: A comparative analysis. Biomolecules, 11(11), Article 1605. https:\/\/doi.org\/10.3390\/biom11111605","journal-title":"Biomolecules"},{"issue":"10","key":"5725_CR26","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.56042\/ijbb.v62i10.16697","volume":"62","author":"M Aruchamy","year":"2025","unstructured":"Aruchamy, M., Snega, R., & Muthupandian, S. (2025). Regulatory role of SLC3A2 in ferroptosis and its impact on head and neck squamous cell carcinoma: A bioinformatics study. Indian Journal of Biochemistry and Biophysics, 62(10), 1069\u20131076. https:\/\/doi.org\/10.56042\/ijbb.v62i10.16697","journal-title":"Indian Journal of Biochemistry and Biophysics"},{"key":"5725_CR27","doi-asserted-by":"publisher","first-page":"101746","DOI":"10.1016\/j.toxrep.2024.101746","volume":"13","author":"S Srinivasan","year":"2024","unstructured":"Srinivasan, S., Mohanprasanth, A., Nadeem, A., & Saravanan, M. (2024). Exploring the anti-cancer and antimetastatic effect of silymarin against lung cancer. Toxicology Reports, 13, 101746. https:\/\/doi.org\/10.1016\/j.toxrep.2024.101746","journal-title":"Toxicology Reports"},{"key":"5725_CR28","doi-asserted-by":"publisher","unstructured":"Jaganathan, S. K. (2012). Growth inhibition by caffeic acid, one of the phenolic constituents of honey, in HCT 15 colon cancer cells. The Scientific World Journal, 2012, 372345. https:\/\/doi.org\/10.1100\/2012\/372345","DOI":"10.1100\/2012\/372345"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05725-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05725-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05725-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:03:13Z","timestamp":1785517393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-026-05725-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5725"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05725-7","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"2 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent is not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication is not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}